A pre-commercial biopharmaceutical company with focus on advancing innovative therapies for musculoskeletal conditions, had no product revenue to-date with their first product under FDA approval. They wanted to build future-proof commercial infrastructure and put up business processes to launch their first drug that was safe, efficacious and affordable. However, they had no pharma data analytics into their target market including, HCPs, HCOs, and affiliations between them. They needed to establish master data management (MDM) as the foundation for mastering HCP data, supporting their sales & marketing, and ensuring faster go-to-market.
Life Sciences Customer 360 built upon Reltio Cloud, helped them not only with their sales force sizing and territory alignment but also HCP-HCO affiliation management and KOL (key opinion leaders) identification. The client was able to connect with a broader ecosystem of partner data & technologies such as NPI (National Provider Identifier), CRM, and QuintilesIMS to enable the most complete HCP view for segmentation and targeting. The solution was deployed quickly to meet the timing of the product approvals and launch. With agile and configurable data model, Reltio solution is geared up to support client’s expected growth including potential future product introductions.